Literature DB >> 8697744

Maximizing the bilateral field advantage on verbal and nonverbal matching tasks.

T E Ludwig1, M A Jeeves.   

Abstract

Research has established that response latencies are generally shorter on visual matching tasks when one target is projected to each hemifield (bilateral presentation) than when both targets are projected to the same hemifield (unilateral presentation). This effect, called the bilateral field advantage (BFA), has recently shown promise as a predictor of callosal dysfunction. As a step toward developing a reliable BFA index, the present study examined two factors that appear to influence the extent of BFA in normal subjects. Twenty-seven right-handed college students performed a verbal matching task (using letter pairs drawn from the set AaBb) and a nonverbal matching task (using dot pattern pairs constructed with 4 dots in a 3 x 3 matrix). Order of task varied across subjects (dots followed by letters, or letters followed by dots, or letter trials and dot trials interleaved at random). The targets were presented either unilaterally or bilaterally. Results revealed a robust BFA for the letter-matching task in all three task order conditions, suggesting that the letter task may be suitable for inclusion in a battery of tasks for clinical assessment. The dot-matching task did not yield a significant BFA when administered as the first task. The dot task BFA increased when the letter task preceded it, and became comparable to the letter task BFA in the interleaved condition.

Entities:  

Mesh:

Year:  1996        PMID: 8697744     DOI: 10.1016/s0010-9452(96)80022-0

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  1 in total

1.  Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation.

Authors:  Michael J Boivin; Farnaz Fatehi; Amy E Phillips-Chan; Julia R Richardson; Amanda N Summers; Steven A Foley
Journal:  BMC Womens Health       Date:  2020-06-23       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.